Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 4
1962 1
1963 2
1966 1
1981 1
1983 1
1984 1
1985 2
1988 2
1989 2
1991 2
1992 2
1993 1
1994 2
1995 2
1996 2
1997 3
1998 6
1999 5
2000 2
2010 1
2011 1
2017 1
2018 1
2019 2
2020 4
2022 7
2023 2
2024 5
2025 8
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean akashita g[au] (5 results)?
Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Pembrolizumab.
Matsuki T, Okada T, Fushimi C, Takahashi H, Okamoto I, Kondo T, Tokashiki K, Hanyu K, Kishida T, Ito T, Yamashita G, Tsukahara K, Masubuchi T, Tada Y, Momiyama K, Asako Y, Hagiwara K, Ikemiyagi H, Yaguchi R, Oridate N, Omura G, Yamashita T. Matsuki T, et al. Among authors: yamashita g. Asia Pac J Clin Oncol. 2025 Sep 8. doi: 10.1111/ajco.70012. Online ahead of print. Asia Pac J Clin Oncol. 2025. PMID: 40920125
Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study.
Okada T, Fushimi C, Matsuki T, Tokashiki K, Takahashi H, Okamoto I, Sato H, Kondo T, Hanyu K, Kishida T, Ito T, Yamashita G, Masubuchi T, Tada Y, Miura K, Omura GO, Yamashita T, Oridate N, Tsukahara K. Okada T, et al. Among authors: yamashita g. Anticancer Res. 2023 Jun;43(6):2717-2724. doi: 10.21873/anticanres.16438. Anticancer Res. 2023. PMID: 37247908
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab.
Hagiwara K, Matsuki T, Okada T, Fushimi C, Kondo T, Takahashi H, Okamoto I, Tokashiki K, Hanyu K, Kishida T, Ito T, Yamashita G, Tsukahara K, Masubuchi T, Tada Y, Momiyama K, Yaguchi R, Oridate N, Omura GO, Yamashita T. Hagiwara K, et al. Among authors: yamashita g. Anticancer Res. 2024 Sep;44(9):4057-4072. doi: 10.21873/anticanres.17235. Anticancer Res. 2024. PMID: 39197913
80 results